Maciej Niczewski , Maciej Dyrbuś , Szymon Gawęda , Anna Danel , Mikołaj Rycerski , Aleksandra Oraczewska , Agata Stanek , Jan Duława , Szymon Skoczyński
{"title":"Association between baseline sodium level, fluid therapy and outcomes in patients with coronavirus disease 2019","authors":"Maciej Niczewski , Maciej Dyrbuś , Szymon Gawęda , Anna Danel , Mikołaj Rycerski , Aleksandra Oraczewska , Agata Stanek , Jan Duława , Szymon Skoczyński","doi":"10.1016/j.advms.2026.04.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>This study aimed to determine a correlation between baseline sodium levels, laboratory test results, and clinical condition as well as the association between sodium level changes during treatment and prognosis of patients with COVID-19.</div></div><div><h3>Materials and methods</h3><div>Our retrospective analysis included 1673 patients hospitalized due to COVID-19 at the Temporary Hospital in Pyrzowice. The patients were treated in accordance with the hospital's treatment protocol, including standard fluid therapy regimen adjusted to oxygen support. The analysis considered data on comorbidities, laboratory tests results, blood gas analysis and computed tomography. The endpoints were the need for treatment in the intensive care unit, length of hospital stay, in-hospital mortality, and long-term mortality.</div></div><div><h3>Results</h3><div>Abnormal sodium levels were found in 35.7% (597) of patients. This correlated with comorbidities and abnormal laboratory test results. Baseline sodium imbalance correlated with longer hospitalization and increased in-hospital and long-term mortality rates. Significant sodium level changes (≥6 mmol/L) were observed in 148 patients which correlated with higher in-hospital and long-term mortality rates.</div></div><div><h3>Conclusions</h3><div>Baseline sodium imbalances and significant sodium level changes during treatment are associated with worse prognosis of COVID-19. According to our best knowledge there are no prospective randomized studies which would compare different fluid strategies in COVID-19 patients. Further prospective studies comparing different fluid therapy strategies and different compositions of fluids should be conducted.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"71 1","pages":"Pages 159-166"},"PeriodicalIF":2.5000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in medical sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1896112626000180","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
This study aimed to determine a correlation between baseline sodium levels, laboratory test results, and clinical condition as well as the association between sodium level changes during treatment and prognosis of patients with COVID-19.
Materials and methods
Our retrospective analysis included 1673 patients hospitalized due to COVID-19 at the Temporary Hospital in Pyrzowice. The patients were treated in accordance with the hospital's treatment protocol, including standard fluid therapy regimen adjusted to oxygen support. The analysis considered data on comorbidities, laboratory tests results, blood gas analysis and computed tomography. The endpoints were the need for treatment in the intensive care unit, length of hospital stay, in-hospital mortality, and long-term mortality.
Results
Abnormal sodium levels were found in 35.7% (597) of patients. This correlated with comorbidities and abnormal laboratory test results. Baseline sodium imbalance correlated with longer hospitalization and increased in-hospital and long-term mortality rates. Significant sodium level changes (≥6 mmol/L) were observed in 148 patients which correlated with higher in-hospital and long-term mortality rates.
Conclusions
Baseline sodium imbalances and significant sodium level changes during treatment are associated with worse prognosis of COVID-19. According to our best knowledge there are no prospective randomized studies which would compare different fluid strategies in COVID-19 patients. Further prospective studies comparing different fluid therapy strategies and different compositions of fluids should be conducted.
期刊介绍:
Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines.
The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments.
Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines.
The journal welcomes submissions from the following disciplines:
General and internal medicine,
Cancer research,
Genetics,
Endocrinology,
Gastroenterology,
Cardiology and Cardiovascular Medicine,
Immunology and Allergy,
Pathology and Forensic Medicine,
Cell and molecular Biology,
Haematology,
Biochemistry,
Clinical and Experimental Pathology.